Format
Sort by

Send to

Choose Destination

Search results

Items: 14

1.

Suitability of stx-PCR directly from fecal samples in clinical diagnostics of STEC.

Tunsjø HS, Kvissel AK, Follin-Arbelet B, Brotnov BM, Ranheim TE, Leegaard TM.

APMIS. 2015 Oct;123(10):872-8. doi: 10.1111/apm.12428. Epub 2015 Aug 25.

PMID:
26303619
2.

Protein kinase a-dependent phosphorylation of serine 119 in the proto-oncogenic serine/arginine-rich splicing factor 1 modulates its activity as a splicing enhancer protein.

Aksaas AK, Eikvar S, Akusjärvi G, Skålhegg BS, Kvissel AK.

Genes Cancer. 2011 Aug;2(8):841-51. doi: 10.1177/1947601911430226.

3.

Two cellular protein kinases, DNA-PK and PKA, phosphorylate the adenoviral L4-33K protein and have opposite effects on L1 alternative RNA splicing.

Törmänen Persson H, Aksaas AK, Kvissel AK, Punga T, Engström Å, Skålhegg BS, Akusjärvi G.

PLoS One. 2012;7(2):e31871. doi: 10.1371/journal.pone.0031871. Epub 2012 Feb 21.

4.

G-patch domain and KOW motifs-containing protein, GPKOW; a nuclear RNA-binding protein regulated by protein kinase A.

Aksaas AK, Larsen AC, Rogne M, Rosendal K, Kvissel AK, Skålhegg BS.

J Mol Signal. 2011 Aug 31;6:10. doi: 10.1186/1750-2187-6-10.

5.

Protein kinase A type I activates a CRE-element more efficiently than protein kinase A type II regardless of C subunit isoform.

Stakkestad Ø, Larsen AC, Kvissel AK, Eikvar S, Ørstavik S, Skålhegg BS.

BMC Biochem. 2011 Feb 8;12:7. doi: 10.1186/1471-2091-12-7.

6.

Splicing factor arginine/serine-rich 17A (SFRS17A) is an A-kinase anchoring protein that targets protein kinase A to splicing factor compartments.

Jarnaess E, Stokka AJ, Kvissel AK, Skålhegg BS, Torgersen KM, Scott JD, Carlson CR, Taskén K.

J Biol Chem. 2009 Dec 11;284(50):35154-64. doi: 10.1074/jbc.M109.056465. Epub 2009 Oct 19.

7.

Epidermal growth factor receptor levels are reduced in mice with targeted disruption of the protein kinase A catalytic subunit.

Oksvold MP, Funderud A, Kvissel AK, Skarpen E, Henanger H, Huitfeldt HS, Skålhegg BS, Ørstavik S.

BMC Cell Biol. 2008 Apr 1;9:16. doi: 10.1186/1471-2121-9-16.

8.

Inactive forms of the catalytic subunit of protein kinase A are expressed in the brain of higher primates.

Larsen AC, Kvissel AK, Hafte TT, Avellan CI, Eikvar S, Rootwelt T, Ørstavik S, Skålhegg BS.

FEBS J. 2008 Jan;275(2):250-62. Epub 2007 Dec 6.

9.

Involvement of the catalytic subunit of protein kinase A and of HA95 in pre-mRNA splicing.

Kvissel AK, Ørstavik S, Eikvar S, Brede G, Jahnsen T, Collas P, Akusjärvi G, Skålhegg BS.

Exp Cell Res. 2007 Aug 1;313(13):2795-809. Epub 2007 May 18.

PMID:
17594903
10.

Expression of complement regulators and receptors on human NT2-N neurons--effect of hypoxia and reoxygenation.

Pedersen ED, Frøyland E, Kvissel AK, Pharo AM, Skålhegg BS, Rootwelt T, Mollnes TE.

Mol Immunol. 2007 Mar;44(9):2459-68. Epub 2006 Nov 20.

PMID:
17116331
11.

Androgen dependent regulation of protein kinase A subunits in prostate cancer cells.

Kvissel AK, Ramberg H, Eide T, Svindland A, Skålhegg BS, Taskén KA.

Cell Signal. 2007 Feb;19(2):401-9. Epub 2006 Jul 25.

PMID:
16949795
12.

Effect of acidosis on IL-8 and MCP-1 during hypoxia and reoxygenation in human NT2-N neurons.

Frøyland E, Pedersen ED, Kvissel AK, Almaas R, Pharo A, Skålhegg BS, Mollnes TE, Rootwelt T.

Brain Res. 2006 Oct 3;1113(1):64-73. Epub 2006 Aug 17.

PMID:
16919250
13.

Protein kinase A (PKA)--a potential target for therapeutic intervention of dysfunctional immune cells.

Skålhegg BS, Funderud A, Henanger HH, Hafte TT, Larsen AC, Kvissel AK, Eikvar S, Ørstavik S.

Curr Drug Targets. 2005 Sep;6(6):655-64. Review.

PMID:
16178799
14.

Induction of Cbeta splice variants and formation of novel forms of protein kinase A type II holoenzymes during retinoic acid-induced differentiation of human NT2 cells.

Kvissel AK, Ørstavik S, Øistad P, Rootwelt T, Jahnsen T, Skålhegg BS.

Cell Signal. 2004 May;16(5):577-87.

PMID:
14751543
Items per page

Supplemental Content

Loading ...
Write to the Help Desk